4//SEC Filing
BARABE TIMOTHY C 4
Accession 0001453687-23-000082
CIK 0001453687other
Filed
Nov 14, 7:00 PM ET
Accepted
Nov 15, 5:15 PM ET
Size
18.5 KB
Accession
0001453687-23-000082
Insider Transaction Report
Form 4
BARABE TIMOTHY C
Director
Transactions
- Disposition to Issuer
Stock Option (Right to Buy)
2023-11-13−10,328→ 0 totalExercise: $11.00Exp: 2026-07-28→ Common Stock (10,328 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2023-11-13−6,410→ 0 totalExercise: $17.47Exp: 2027-06-15→ Common Stock (6,410 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2023-11-13−10,000→ 0 totalExercise: $12.75Exp: 2028-06-14→ Common Stock (10,000 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2023-11-13−20,000→ 0 totalExercise: $3.00Exp: 2030-06-18→ Common Stock (20,000 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2023-11-13−40,000→ 0 totalExercise: $4.01Exp: 2031-03-29→ Common Stock (40,000 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2023-11-13−40,000→ 0 totalExercise: $3.31Exp: 2032-01-02→ Common Stock (40,000 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2023-11-13$0.93/sh−87,500$81,375→ 0 totalExercise: $1.13Exp: 2033-01-01→ Common Stock (87,500 underlying)
Footnotes (7)
- [F1]This option, which provided for vesting in thirty-six (36) substantially equal monthly installments over three years following the date of grant on July 29, 2016, was canceled in the merger (the "Merger") between Selecta Biosciences, Inc. and Cartesian Therapeutics, Inc.
- [F2]This option, which provided for vesting in full on June 14, 2018, was canceled in the Merger.
- [F3]This option, which provided for vesting in full on June 13, 2019, was canceled in the Merger.
- [F4]This option, which provided for vesting in full on June 17, 2021, was canceled in the Merger.
- [F5]This option, which provided for vesting in full on March 30, 2022, was canceled in the Merger.
- [F6]This option, which provided for vesting in full on January 3, 2023, was canceled in the Merger.
- [F7]This option, which provided for vesting in full on January 2, 2024, was canceled in the Merger in exchange for a cash payment of $81,375, representing the difference between the exercise price of the option and $2.06, the Cash-out Amount as applied in the Merger.
Documents
Issuer
Cartesian Therapeutics, Inc.
CIK 0001453687
Entity typeother
Related Parties
1- filerCIK 0001237409
Filing Metadata
- Form type
- 4
- Filed
- Nov 14, 7:00 PM ET
- Accepted
- Nov 15, 5:15 PM ET
- Size
- 18.5 KB